United States was Gilead Sciences’s largest region in fiscal 2018, bringing in $32.68B of $44.53B (73%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $42.47B | $38.71B | $36.39B | $32.68B | ||||||
| U.S | — | $38.71B | $36.39B | — | ||||||
| Europe | $15.06B | $12.73B | $10.62B | $8.01B | ||||||
| Other International | — | $9.34B | $5.20B | $3.84B | ||||||
| Other Countries | $7.75B | $9.34B | $5.20B | — | ||||||
| France | — | — | — | — | ||||||
| Spain | — | — | — | — | ||||||
| Switzerland | — | — | — | — | ||||||
| United Kingdom | — | — | — | — | ||||||
| Italy | — | — | — | — | ||||||
| Germany | — | — | — | — | ||||||
| Japan | — | — | — | — | ||||||
| Total | $65.28B | $108.83B | $93.81B | $44.53B |
Gilead Sciences brought in $44.53B from its three regions in fiscal 2018, the year ended December 31, 2018. Gilead Sciences regrouped these regions after fiscal 2017, so the total does not compare directly with that year's $93.81B. United States was the largest at $32.68B (73.4%), ahead of Europe at $8.01B (18.0%) and Other International at $3.84B (8.6%).
Compared with fiscal 2017, every region above 2% of revenue shrank. United States held up best, down 10.2% to $32.68B, and Other International fell the most, down 26.2% to $3.84B.
Gilead Sciences began breaking out Other International in fiscal 2016, when it brought in $9.34B. Gilead Sciences stopped reporting U.S ($36.39B in fiscal 2017) and Other Countries ($5.20B in fiscal 2017) as separate regions.
United States was Gilead Sciences’s largest region in fiscal 2008, bringing in $5.71B of $10.67B (54%).
| Geography | FY 2008 |
|---|---|
| United States | $5.71B |
| France | $791.34M |
| Other Countries | $738.11M |
| Spain | $713.21M |
| Other European Countries | $693.44M |
| United Kingdom | $594.55M |
| Italy | $554.88M |
| Germany | $484.39M |
| Switzerland | $386.63M |
| Total | $10.67B |
Gilead Sciences brought in $10.67B from its nine regions in fiscal 2008, the year ended December 31, 2008. United States was the largest at $5.71B (53.6%), ahead of France at $791.34M (7.4%) and Other Countries at $738.11M (6.9%). The other six regions brought in $3.43B combined.
Gilead Sciences (GILD) reports its revenue by geography. In fiscal 2018, United States was its largest region, bringing in $32.68B (73.4% of the total), followed by Europe at $8.01B (18.0%).
United States was Gilead Sciences' largest region in fiscal 2018, bringing in $32.68B, or 73.4% of the $44.53B total across its three regions.
Every figure comes from Gilead Sciences' annual financial filings, as reported. Each line keeps the name Gilead Sciences gives it, and years follow its fiscal calendar.
Gilead Sciences' revenue by geography goes back to fiscal 2009, with figures through fiscal 2018. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.